- Featured Product
- KD/KO Validated
EIF4G1 Polyclonal antibody
EIF4G1 Polyclonal Antibody for WB, IHC, IF/ICC, IP, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human and More (1)
Applications
WB, IHC, IF/ICC, IP, CoIP, ELISA
Conjugate
Unconjugated
Cat no : 15704-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | BxPC-3 cells, HeLa cells, HepG2 cells |
Positive IP detected in | HeLa cells |
Positive IHC detected in | human breast cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Positive IF/ICC detected in | HepG2 cells, Ethacrynic acid treated HepG2 cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:2000-1:16000 |
Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
KD/KO | See 1 publications below |
WB | See 16 publications below |
IHC | See 4 publications below |
IF | See 6 publications below |
IP | See 1 publications below |
CoIP | See 1 publications below |
Product Information
15704-1-AP targets EIF4G1 in WB, IHC, IF/ICC, IP, CoIP, ELISA applications and shows reactivity with human samples.
Tested Reactivity | human |
Cited Reactivity | human, mouse |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | EIF4G1 fusion protein Ag8342 相同性解析による交差性が予測される生物種 |
Full Name | eukaryotic translation initiation factor 4 gamma, 1 |
Calculated molecular weight | 1600 aa, 176 kDa |
Observed molecular weight | 250 kDa |
GenBank accession number | BC007788 |
Gene symbol | EIF4G1 |
Gene ID (NCBI) | 1981 |
RRID | AB_2261979 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
Eukaryotic cellular messenger RNAs are posttranscriptionally modified by addition of an m(7)GTP moiety to the 5-prime terminus, referred to as a cap. Recognition of the cap structure and unwinding of mRNA secondary structure during the initiation phase of protein synthesis is catalyzed by initiation factors of the eIF4 group. EIF4G1, a subunit of eIF4 gamma, forms various complexes with the other eIF4 polypeptides [PMID: 7601469]. Mutations in the EIF4G1 gene, encoding a component of the eIF4F translation initiation complex, were recently reported as a possible cause for the autosomal dominant form of Parkinson's disease [PMID:22658323]. The calcualted molecular weight of EIF4G1 is 175 kDa, but modified EIF4G1 is about 220-240 kDa. (PMID: 18426977 )
Protocols
Product Specific Protocols | |
---|---|
WB protocol for EIF4G1 antibody 15704-1-AP | Download protocol |
IHC protocol for EIF4G1 antibody 15704-1-AP | Download protocol |
IF protocol for EIF4G1 antibody 15704-1-AP | Download protocol |
IP protocol for EIF4G1 antibody 15704-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Mol Cell The oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation. | ||
J Extracell Vesicles Extracellular vesicles rich in HAX1 promote angiogenesis by modulating ITGB6 translation. | ||
Proc Natl Acad Sci U S A Cellular cap-binding protein, eIF4E, promotes picornavirus genome restructuring and translation. | ||
PLoS Genet SAMHD1 Inhibits LINE-1 Retrotransposition by Promoting Stress Granule Formation. | ||
Diabetes Translational Factor eIF4G1 Regulates Glucose Homeostasis and Pancreatic β-Cell Function.
| ||
Virol Sin Baicalein suppresses Coxsackievirus B3 replication by inhibiting caspase-1 and viral protease 2A |